Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▼ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Bruker Corp. | 9 | 2 | 0 | 0 | €60.78 | €82.85 | 36.318% |
| Hutchison China MediTech Ltd ADR | 4 | 0 | 0 | 0 | €16.20 | €33.46 | 106.514% |
| Intellia Therapeutics Inc | 15 | 1 | 2 | 0 | €20.31 | €60.53 | 198.021% |
| AbbVie Inc. | 34 | 0 | 3 | 0 | €177.58 | €181.45 | 2.178% |
| Merck KGaA | 5 | 1 | 2 | 0 | €175.95 | €172.00 | -2.245% |
| Cryolife Inc. | 1 | 1 | 0 | 0 | €23.75 | €10.00 | -57.895% |
| Avadel Pharmaceuticals plc ADR | 1 | 0 | 0 | 0 | €15.10 | €23.00 | 52.318% |
| Cerus Corp. | 4 | 0 | 0 | 0 | €2.04 | €3.26 | 59.623% |
| Novartis AG ADR | 3 | 0 | 0 | 0 | €109.50 | €112.40 | 2.646% |
| Compugen Ltd. | 3 | 2 | 0 | 0 | €1.83 | €3.66 | 99.815% |
| Sarepta Therapeutics | 1 | 0 | 0 | 0 | €125.00 | €130.00 | 4.000% |
| Acadia Pharmaceuticals | 35 | 1 | 7 | 0 | €14.13 | €29.92 | 111.790% |
| MacroGenics Inc. | 14 | 0 | 2 | 0 | €3.18 | €12.31 | 286.950% |
| CONMED Corp. | 15 | 2 | 4 | 0 | €63.00 | €98.42 | 56.219% |
| Repligen Corp. | 15 | 0 | 0 | 0 | €130.50 | €178.01 | 36.408% |
| Biocryst Pharmaceuticals | 7 | 0 | 1 | 0 | €7.87 | €11.13 | 41.490% |
| Henry Schein Inc. | 15 | 1 | 3 | 0 | €63.84 | €76.08 | 19.172% |
| Adaptimmune Therapeutics PLC ADR | 1 | 0 | 0 | 0 | €1.15 | €2.00 | 73.913% |
| Alnylam Pharmace. | 46 | 1 | 8 | 1 | €237.70 | €271.50 | 14.221% |
| Eckert & Ziegler Strahlen- und Medizintechnik AG | 6 | 0 | 0 | 0 | €43.54 | €95.00 | 118.190% |
| Fresenius SE & Co. KGaA | 3 | 1 | 0 | 1 | €33.33 | - | - |
| Fagron N.V. | 1 | 0 | 0 | 0 | €19.20 | €20.00 | 4.167% |
| Gerresheimer AG | 4 | 0 | 0 | 0 | €103.00 | - | - |
| Hologic Inc. | 19 | 0 | 2 | 0 | €73.50 | €83.38 | 13.437% |
| Steris Corp. | 1 | 0 | 0 | 0 | €220.00 | - | - |